These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7195793

  • 1. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH, Andrews FA, Sarosi GA.
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [Abstract] [Full Text] [Related]

  • 2. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH, Sarosi GA.
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
    Beggs WH, Sarosi GA, Steele NM.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631
    [Abstract] [Full Text] [Related]

  • 4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 5. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [Abstract] [Full Text] [Related]

  • 6. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R.
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [Abstract] [Full Text] [Related]

  • 7. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 8. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A.
    Chemotherapy; 1978 Jul; 24(1):2-16. PubMed ID: 338264
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of yeasts to amphotericin B and 5-fluorocytosine.
    Abdul-Samad S, Arumugham G, Yasin MS.
    Malays J Pathol; 1989 Aug; 11():37-42. PubMed ID: 2632999
    [Abstract] [Full Text] [Related]

  • 10. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH, Sarosi GA.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [Abstract] [Full Text] [Related]

  • 11. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.
    Mazens MF, Andrews GP, Bartlett RC.
    Antimicrob Agents Chemother; 1979 Mar; 15(3):475-7. PubMed ID: 464576
    [Abstract] [Full Text] [Related]

  • 12. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
    Vakil R, Knilans K, Andes D, Kwon GS.
    Pharm Res; 2008 Sep; 25(9):2056-64. PubMed ID: 18415047
    [Abstract] [Full Text] [Related]

  • 13. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract] [Full Text] [Related]

  • 14. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV, Tubert TA, Chapin K, Rinaldi MG.
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 Oct; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 16. Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.
    Rubinstein E.
    Chemotherapy; 1979 Oct; 25(5):249-53. PubMed ID: 573195
    [Abstract] [Full Text] [Related]

  • 17. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
    Hamilton JD, Elliott DM.
    J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
    [Abstract] [Full Text] [Related]

  • 18. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B, Budak A, Macura A, Laskownicka Z.
    Med Dosw Mikrobiol; 1978 Feb; 30(1):43-8. PubMed ID: 692181
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM, Sabaté M, Gallach C, Carrillo A, Madrenys N.
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [Abstract] [Full Text] [Related]

  • 20. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS, Bartlett MS, Smith JW.
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.